Skip to main content
Clinical Trials/CTRI/2024/07/070419
CTRI/2024/07/070419
Not yet recruiting
未知

A clinical Study to evaluate the skin irritation potential of FARE Labs Baby Lotion (DBM-003) on healthy human subjects - NI

FARE Labs Private Limited0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
FARE Labs Private Limited
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
FARE Labs Private Limited

Eligibility Criteria

Inclusion Criteria

  • 1\. Voluntary man or women between 18 and 65 years.
  • 2\. Photo type III to V.
  • 3\. Having apparently healthy skin on test area
  • 4\. For whom the investigator considers that the compliance will be correct.
  • 5\. Cooperating, informed of the need and duration of the examinations and ready to comply with protocol procedures.
  • 6\. Having signed a Consent Form.
  • 7\. Willingness to avoid intense UV exposure on test site (sun or artificial UV) during the course of the study.
  • 8\. Willingness to avoid excessive water contact (for example swimming) or activity which causes excessive sweating (that is exercise, sauna), during the course of the study.
  • 9\. Should be able to read and write (in English, Hindi or local language).
  • 10\. Having valid proof of identity and age.

Exclusion Criteria

  • 1\. Pregnant or nursing mothers
  • 2\.Scars, excessive terminal hair or tattoo on the studied area
  • 3\.Henna tattoo anywhere on the body (in case of studies involving hair dyes)
  • 4\.Dermatological infection or pathology on the level of studied area
  • 5\.Hypersensitivity, allergy antecedent (to any cosmetic product, raw material or hair dye)
  • 6\.Any clinically significant systemic or cutaneous disease, which may interfere with study treatment or procedures
  • 7\.Chronic illness which may influence the outcome of the study
  • 8\.Subjects on any medical treatment either systemic or topical which may interfere with the performance of the study treatment (presently or in the past 1 month)
  • 9\.Subject in an exclusion period or participating in another food, cosmetic or therapeutic trial.

Outcomes

Primary Outcomes

Not specified

Similar Trials